New NIH Center May Offer More Opportunity For FDA Collaboration
This article was originally published in The Gray Sheet
Executive SummaryFDA hopes the National Institute of Health’s proposed new National Center for Advancing Translational Science will trigger more collaboration between the two agencies through shared grant making, FDA Commissioner Margaret Hamburg said last week.
You may also be interested in...
The sequester is making it difficult to fund new projects, “no matter how high a priority,” National Center for Advancing Translational Sciences Director Christopher Austin noted during a June 25 teleconference to discuss Institute of Medicine recommendations for strengthening the Clinical and Translational Science Awards program.